Clinical Trial Update: Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD [Phase 2]

View source ↗

Summary

Phase 2 pilot trial comparing two dosing regimens of TP-03 for Meibomian Gland Dysfunction and Blepharitis (with Demodex infestation); safety and efficacy resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis
• Demodex Infestation
• Meibomian Gland Dysfunction

Drugs mentioned

• TP-03

Snippet

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Meibomian Gland Dysfunction, Blepharitis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-01